PIN1 and cancer: Used together, ATO and ATRA cooperatively ablate Pin1, thereby blocking numerous cancer-driving pathways and inhibiting TICs and tumor growth of TNBC, similar to Pin1 KO in human cells and in orthotopic tumor models, including PDOX.